Acute lymphoblastic leukemia and down syndrome: 6-mercaptopurine and methotrexate metabolites during maintenance therapy.

Anna ØstergaardCathrine BohnstedtKathrine GrellMatilda DegnBernward ZellerMervi TaskinenSolveig HafsteinsdottirHelga BjörgvinsdóttirMats HeymanPeter HoogerbruggeKjeld Schmiegelownull null

Published in: Leukemia (2020)

Keyphrases

acute lymphoblastic leukemia
ms ms
allogeneic hematopoietic stem cell transplantation
high dose
stem cells
low dose
acute myeloid leukemia
cell therapy
smoking cessation
replacement therapy